Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Cancer Research
Published October 8, 2026
FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC.
October 9, 2026
Medspoke
Medspoke
Journal of Clinical Oncology (JCO)
Published October 8, 2026
00:00
--:--
Prognostic Impact of Telomere Maintenance Mechanisms in Neuroblastoma.
October 9, 2026
Share
Prognostic Impact of Telomere Maintenance Mechanisms in Neuroblastoma.
https://www.medspoke.co/channel_journal?id=686&tap_id=15297
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Journal of Clinical Oncology (JCO)
Published October 8, 2026
RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Findin...
October 9, 2026
Why are you reporting this TALK?
